The NPNC treatment did not change intra-tumor MDSC number or percentage (Supplementary Figures 6D, I), but reduced CD11b+Gr-1+ cell percentages in tdLNs, spleen and blood (Supplementary Figures 7C, E, F). Here, ITGAM is linked to neoplasm.